These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23842608)

  • 1. Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment.
    Blasi G; De Virgilio C; Papazacharias A; Taurisano P; Gelao B; Fazio L; Ursini G; Sinibaldi L; Andriola I; Masellis R; Romano R; Rampino A; Di Giorgio A; Lo Bianco L; Caforio G; Piva F; Popolizio T; Bellantuono C; Todarello O; Kleinman JE; Gadaleta G; Weinberger DR; Bertolino A
    JAMA Psychiatry; 2013 Sep; 70(9):921-30. PubMed ID: 23842608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics.
    Blasi G; Selvaggi P; Fazio L; Antonucci LA; Taurisano P; Masellis R; Romano R; Mancini M; Zhang F; Caforio G; Popolizio T; Apud J; Weinberger DR; Bertolino A
    Neuropsychopharmacology; 2015 Jun; 40(7):1600-8. PubMed ID: 25563748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
    Bertolino A; Caforio G; Blasi G; De Candia M; Latorre V; Petruzzella V; Altamura M; Nappi G; Papa S; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
    Am J Psychiatry; 2004 Oct; 161(10):1798-805. PubMed ID: 15465976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone release.
    Singh RK; Jia C; Garcia F; Carrasco GA; Battaglia G; Muma NA
    J Psychopharmacol; 2010 Jul; 24(7):1079-88. PubMed ID: 19304867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex.
    Carli M; Calcagno E; Mainolfi P; Mainini E; Invernizzi RW
    Psychopharmacology (Berl); 2011 Apr; 214(3):639-52. PubMed ID: 21052982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of serotonin (5-HT) 2A-receptor and transporter (5HTT) gene polymorphism upon the effect of olanzapine].
    Iwahashi K; Murayama O; Aoki J; Watanabe M; Ishigouoka J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):141-4. PubMed ID: 19764480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
    Lian J; Pan B; Deng C
    Pharmacol Rep; 2016 Oct; 68(5):1028-35. PubMed ID: 27428765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.
    Maffioletti E; Valsecchi P; Minelli A; Magri C; Bonvicini C; Barlati S; Sacchetti E; Vita A; Gennarelli M
    Drug Dev Res; 2020 Sep; 81(6):754-761. PubMed ID: 32462699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
    Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S
    J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study.
    Abler B; Erk S; Walter H
    Psychopharmacology (Berl); 2007 Apr; 191(3):823-33. PubMed ID: 17265148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.
    Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A
    Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with olanzapine is associated with modulation of the default mode network in patients with Schizophrenia.
    Sambataro F; Blasi G; Fazio L; Caforio G; Taurisano P; Romano R; Di Giorgio A; Gelao B; Lo Bianco L; Papazacharias A; Popolizio T; Nardini M; Bertolino A
    Neuropsychopharmacology; 2010 Mar; 35(4):904-12. PubMed ID: 19956088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
    Willins DL; Berry SA; Alsayegh L; Backstrom JR; Sanders-Bush E; Friedman L; Roth BL
    Neuroscience; 1999; 91(2):599-606. PubMed ID: 10366017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 5-HT
    García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia.
    Blasi G; Popolizio T; Taurisano P; Caforio G; Romano R; Di Giorgio A; Sambataro F; Rubino V; Latorre V; Lo Bianco L; Fazio L; Nardini M; Weinberger DR; Bertolino A
    Psychiatry Res; 2009 Jul; 173(1):31-8. PubMed ID: 19428222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
    Blasi G; Napolitano F; Ursini G; Di Giorgio A; Caforio G; Taurisano P; Fazio L; Gelao B; Attrotto MT; Colagiorgio L; Todarello G; Piva F; Papazacharias A; Masellis R; Mancini M; Porcelli A; Romano R; Rampino A; Quarto T; Giulietti M; Lipska BK; Kleinman JE; Popolizio T; Weinberger DR; Usiello A; Bertolino A
    Am J Psychiatry; 2013 Aug; 170(8):868-76. PubMed ID: 23598903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
    Muguruza C; Miranda-Azpiazu P; Díez-Alarcia R; Morentin B; González-Maeso J; Callado LF; Meana JJ
    Neuropharmacology; 2014 Nov; 86():311-8. PubMed ID: 25150943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.